Obstetrical and neonatal case definitions for immunization safety data

por Chen, Robert T., Moro, Pedro L., Bauwens, Jorgen, Bonhoeffer, Jan
Publicado 2016

Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 201...

por Havers, Fiona P., Moro, Pedro L., Hunter, Paul, Hariri, Susan, Bernstein, Henry
Publicado 2020

Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013−May 31, 2015

por Haber, Penina, Moro, Pedro L., Lewis, Paige, Woo, Emily Jane, Jankosky, Christopher, Cano, Maria
Publicado 2016

Post-Marketing Surveillance of Human Rabies Diploid Cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990‒2015

por Moro, Pedro L., Woo, Emily Jane, Paul, Wendy, Lewis, Paige, Petersen, Brett W., Cano, Maria
Publicado 2016

Introduction of new vaccines for immunization in pregnancy – Programmatic, regulatory, safety and ethical considerations

por Kochhar, Sonali, Edwards, Kathryn M., Ropero Alvarez, Alba Maria, Moro, Pedro L., Ortiz, Justin R.
Publicado 2019

Economic Impact of Cystic Echinococcosis in Peru

por Moro, Pedro L., Budke, Christine M., Schantz, Peter M., Vasquez, Julio, Santivañez, Saul J., Villavicencio, Jaime
Publicado 2011

Notes from the Field: Safety Monitoring of Novavax COVID-19 Vaccine Among Persons Aged ≥12 Years — United States, July 13, 2022–March 13, 2023

por Romanson, Brittney, Moro, Pedro L., Su, John R., Marquez, Paige, Nair, Narayan, Day, Brendan, DeSantis, Allison, Shimabukuro, Tom T.
Publicado 2023

Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021–June 30, 2022

por Moro, Pedro L., Zhang, Bicheng, Ennulat, Carol, Harris, Margaret, McVey, Rachel, Woody, Gina, Marquez, Paige, McNeil, Michael M., Su, John R.
Publicado 2023

Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months–5 Years — United States, June 17, 2022–May 7, 2023

por Hause, Anne M., Marquez, Paige, Zhang, Bicheng, Moro, Pedro L., Myers, Tanya R., Bradley, Colin, Bazel, Samaneh, Panchanathan, Sarada S., Shimabukuro, Tom T., Shay, David K.
Publicado 2023

Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 – October 202...

por Moro, Pedro L., Olson, Christine K., Clark, Elizabeth, Marquez, Paige, Strid, Penelope, Ellington, Sascha, Zhang, Bicheng, Mba-Jonas, Adamma, Alimchandani, Meghna, Cragan, Janet, Moore, Cynthia
Publicado 2022

COVID-19 vaccine safety inquiries to the centers for disease control and prevention immunization safety office

por Miller, Elaine R., Moro, Pedro L., Shimabukuro, Tom T., Carlock, Grace, Davis, Shaeyla N., Freeborn, Emma M., Roberts, Amy L., Gee, Julianne, Taylor, Allan W., Gallego, Ruth, Suragh, Tiffany, Su, John R.
Publicado 2023

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

por Shimabukuro, Tom T., Kim, Shin Y., Myers, Tanya R., Moro, Pedro L., Oduyebo, Titilope, Panagiotakopoulos, Lakshmi, Marquez, Paige L., Olson, Christine K., Liu, Ruiling, Chang, Karen T., Ellington, Sascha R., Burkel, Veronica K., Smoots, Ashley N., Green, Caitlin J., Licata, Charles, Zhang, Bicheng C., Alimchandani, Meghna, Mba-Jonas, Adamma, Martin, Stacey W., Gee, Julianne M., Meaney-Delman, Dana M.
Publicado 2021